Skip to content

Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer

Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer: A Pilot Study

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01632956
Enrollment
0
Registered
2012-07-04
Start date
2012-06-30
Completion date
2014-06-30
Last updated
2014-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chinese Immigrants With Breast Cancer

Keywords

Support Groups, Breast cancer, Mandarin speaking, 12-105

Brief summary

There are few breast cancer support groups that focus on the specific needs of Chinese women. The purpose of this study is to learn about two different ways of providing support groups to help women of Chinese descent cope with the difficulties of a diagnosis of breast cancer and its treatment. The investigators want to learn about how best to support Chinese women with breast cancer by providing two different types of groups: an in-person support group and a virtual (online/phone) support group.

Interventions

Each support group will consist of 12 sessions. Thirty-two breast cancer patients of Chinese descent will be recruited to participate in the support groups (16 in the inperson groups and 16 in the virtual groups).

Each support group will consist of 12 sessions. Thirty-two breast cancer patients of Chinese descent will be recruited to participate in the support groups (16 in the inperson groups and 16 in the virtual groups).

Sponsors

Cancer Support Community
CollaboratorUNKNOWN
CHARLES B WANG COMMUNITY HEALTH CENTER
CollaboratorUNKNOWN
Queens Health Network
CollaboratorOTHER
Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Female * Non-US born * Resident in the US \< 20 years * Of Chinese descent * Age 21 years through 80 years * Language spoken: Mandarin * Diagnosis of breast cancer within 3 months prior to recruitment \*Not required that breast cancer is the patients' first and/or only cancer diagnosis * Currently receiving cancer treatment; * Will be living continuously in the US for the next year * Has a telephone that he/she is willing to use for the study

Exclusion criteria

* Presence of cognitive impairment disorder (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection * Another household member is already enrolled. * Prior participation in a cancer support group

Design outcomes

Primary

MeasureTime frameDescription
feasibility1 yearTo pilot and evaluate the feasibility of information-based, culturally-tailored in-person and virtual support groups for Chinese patients with breast cancer. The feasibility of participation in the in-person and virtual support groups will be measured by documenting patient accrual to the pilot study and attendance at the support groups.

Secondary

MeasureTime frameDescription
To compare the impact of participation1 yearin the in-person versus virtual support groups on quality of life (QOL), pain, psychosocial outcomes (distress, depression, anxiety, self-efficacy in coping with cancer), and perceived social support. These outcomes will be measured through a baseline and exit Outcomes Survey.
To assess satisfaction with the support groups1 yearAll participants will complete the Brief Support Group Survey at the end of each support meeting to assess satisfaction with and to provide feedback on the usefulness of the meeting and the information presented, ease of understanding and cultural appropriateness of the information, effectiveness of the facilitator, and suggestions for change or improvement.
To assess Internet use1 yearamong support group participants. All patients approached for study participation will complete the Screening Tool, which includes questions related to Internet use. The Screening Tool will be used for all eligible patients (patients refusing to participate will still be asked to complete the screening tool).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026